You are here

CDMOs

Catalent signs on to produce Aurinia's newly approved lupus nephritis drug

Catalent signs on to produce Aurinia's newly approved lupus nephritis drug

Fierce Pharma

Aurinia Pharmaceuticals

lupus nephritis

Flag link:

Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

Biopharma Reporter

Flag link:

Charles River Dives Deep Into Cell and Gene Therapy With Cognate BioServices Acquisition

Charles River Dives Deep Into Cell and Gene Therapy With Cognate BioServices Acquisition

BioSpace

Charles River Labs

Cognate BioServices

Flag link:

Quotient, buoyed by Covid-19 work, buys Arcinova in effort to build end-to-end CDMO brand

Quotient, buoyed by Covid-19 work, buys Arcinova in effort to build end-to-end CDMO brand

Endpoints

Flag link:

Fujifilm's CDMO carves foothold in Boston biotech hub with new HQ focused on viral vectors, gene therapies

Fujifilm's CDMO carves foothold in Boston biotech hub with new HQ focused on viral vectors, gene therapies

Endpoints

Fujifilm Diosynth Biotechnologies

Flag link:

Continuing rapid expansion, Thermo Fisher says it will add on plasmid DNA manufacturing site in California

Continuing rapid expansion, Thermo Fisher says it will add on plasmid DNA manufacturing site in California

Endpoints

Flag link:

New antibody-drug conjugate partnership has oncology focus

New antibody-drug conjugate partnership has oncology focus

Biopharma Reporter

Sterling Pharma Solutions

antibody-drug conjugate

Flag link:

Thermo Fisher aims to boost its clinical offerings with German expansion — including cold chain for the Covid-19 effort

Thermo Fisher aims to boost its clinical offerings with German expansion — including cold chain for the Covid-19 effort

Endpoints

Flag link:

India-based CDMO Piramal sketches out $32M upgrade to Michigan drug ingredient facility

India-based CDMO Piramal sketches out $32M upgrade to Michigan drug ingredient facility

Fierce Pharma

drug manufacturing

Flag link:

With new CEO on board, Germany's Vibalogics lays out $150M for Boston viral vector site

With new CEO on board, Germany's Vibalogics lays out $150M for Boston viral vector site

Fierce Biotech

drug manufacturing

Flag link:

California CDMO plots ambitious expansion in Geneva in biologics manufacturing play

California CDMO plots ambitious expansion in Geneva in biologics manufacturing play

Fierce Biotech

JSR Life Sciences

Flag link:

Michigan’s GRAM Inks COVID-19 Vaccine Manufacturing Deal with J&J

Michigan’s GRAM Inks COVID-19 Vaccine Manufacturing Deal with J&J

BioSpace

drug manufacturing

Flag link:

Epilepsy gene therapy candidate moves closer to clinical study phase

Epilepsy gene therapy candidate moves closer to clinical study phase

Biopharma Reporter

Cobra Biologics

Flag link:

J&J sews up 5 years of coronavirus vaccine supply in $480M-plus deal with Emergent

J&J sews up 5 years of coronavirus vaccine supply in $480M-plus deal with Emergent

Fierce Pharma

Emergent BioSolutions

drug manufacturing

Flag link:

Oxford Biomedica snags manufacturing equipment to ramp up production of COVID-19 vaccine

Oxford Biomedica snags manufacturing equipment to ramp up production of COVID-19 vaccine

Fierce Pharma

Oxford BioMedica

drug manufacturing

Flag link:

GlaxoSmithKline consumer hiving off Canada plant with 400 workers to Taiwan CDMO

GlaxoSmithKline consumer hiving off Canada plant with 400 workers to Taiwan CDMO

Fierce Pharma

Bora Pharmaceuticals

drug manufacturing

consumer health

Flag link:

New CDMO allows Acacia Pharma to win FDA approval of nausea drug

New CDMO allows Acacia Pharma to win FDA approval of nausea drug

Fierce Pharma

post-operative nausea and vomiting

Flag link:

Catalent laying out $315M to snatch another gene therapy CDMO

Catalent laying out $315M to snatch another gene therapy CDMO

Fierce Pharma

Paragon Services

Flag link:

Deerfield vaults to the top of cell and gene therapy CDMO game with $1.1B facility at Philadelphia's newest biopharma hub

Deerfield vaults to the top of cell and gene therapy CDMO game with $1.1B facility at Philadelphia's newest biopharma hub

Endpoints

Deerfield Management

Flag link:

$50M cell and viral vector manufacturing operation backed by Harvard

$50M cell and viral vector manufacturing operation backed by Harvard

Fierce Pharma

Flag link:

Pages